CAPN3 Gene Muscular Dystrophy Limb-Girdle Type 2A Genetic Test
At DNA Labs UAE, we offer the CAPN3 Gene Muscular Dystrophy Limb-Girdle Type 2A Genetic Test. This test is designed to diagnose and analyze the CAPN3 gene, which is associated with a type of muscular dystrophy called limb-girdle muscular dystrophy type 2A (LGMD2A).
Test Components and Price
The CAPN3 Gene Muscular Dystrophy Limb-Girdle Type 2A Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
Once the sample is received, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes.
Test Type and Doctor
The CAPN3 Gene Muscular Dystrophy Limb-Girdle Type 2A Genetic Test falls under the category of neurological disorders. It is recommended to consult with a neurologist for this test.
Test Department and Pre Test Information
The test is conducted in our Genetics department. Prior to the test, it is important to provide the clinical history of the patient who is going for the CAPN3 Gene Muscular Dystrophy Limb-Girdle Type 2A NGS Genetic DNA Test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with this genetic disorder.
Test Details
Limb-girdle muscular dystrophy type 2A (LGMD2A) primarily affects the muscles of the hips and shoulders, resulting in progressive muscle weakness and wasting. The CAPN3 gene is associated with this type of muscular dystrophy. The NGS genetic testing technique allows for a comprehensive analysis of the CAPN3 gene, enabling a more accurate diagnosis and potentially identifying specific mutations that can inform treatment and management strategies.
Please note that NGS genetic testing for LGMD2A should be performed by a healthcare professional or genetic counselor specialized in genetic testing and interpretation. They will be able to provide more specific information and guidance based on an individual’s personal and family medical history.
| Test Name | CAPN3 Gene Muscular dystrophy limb-girdle type 2A Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CAPN3 Gene Muscular dystrophy, limb-girdle type 2A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CAPN3 Gene Muscular dystrophy, limb-girdle type 2A |
| Test Details |
The CAPN3 gene is associated with a type of muscular dystrophy called limb-girdle muscular dystrophy type 2A (LGMD2A). This genetic disorder primarily affects the muscles of the hips and shoulders, leading to progressive muscle weakness and wasting. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of LGMD2A, NGS genetic testing can identify mutations or variations in the CAPN3 gene that may be responsible for the condition. This type of testing can provide a comprehensive analysis of the gene, allowing for a more accurate diagnosis and potentially identifying specific mutations that can inform treatment and management strategies. It’s important to note that NGS genetic testing for LGMD2A is typically performed by a healthcare professional or genetic counselor who specializes in genetic testing and interpretation. They will be able to provide more specific information and guidance based on an individual’s personal and family medical history. |
